, an end-to-end drug development company specializing in the 505(b)(2) process, has announced today its expansion into The Research Triangle Park (RTP) with the opening of a new office. The new location will pave the way for additional opportunities and service offerings, as well as streamlining client service.

Camargo’s decision to expand its reach to the east coast, specifically RTP, abides with the Company’s overall growth goals and global service coverage. RTP, the largest research park in the nation, is a 7,000-acre development that is home to more than 170 companies. 

Camargo is focused on global drug development through the 505(b)(2) process and provides a full spectrum of services from discovery through each phase of clinical development.